［1］Larach MG, Localio AR, Allen GC, Denborough MA, Ellis FR, Gronert GA, et al. A clinical grading scale to predict malignant hyperthermia susceptibility［J］. Anesthesiology,1994,80(4):771-779. ［2］Hopkins PM. Malignant hyperthermia: advances in clinical management and diagnosis［J］. Br J Anaesth, 2000, 85(1): 118-128. ［3］Hollander AS, Olney RC, Blackett PR, Marshall BA. Fatal malignant hyperthermia-like syndrome with rhabdomyolysis complicating the presentation of diabetes mellitus in adolescent males［J］. Pediatrics, 2003, 111(6pt 1): 1447-1452. ［4］Chamley D, Pollock NA, Stowell KM, Brown RL. Malignannt hyperthermia in infancy and identification of novel RYR1 mutation［J］. Br J Anaesth, 2000, 84(4): 500-504. ［5］张晓敏,杨冰岩,王维群.新生儿麻醉后恶性高热一例［J］.中华小儿外科杂志,2003,24(4):365. ［6］韩晗,邵加庆,张明军,魏军霞,梁楠.恶性高热的诊断与治疗［J］.中国全科医学,2008,11(2B):314-317. ［7］Gerbershagen MU, Fiege M, Weisshorn R, Kolodzile K, Esch JS, Wappler F.Cumulative and bolus in vitro contracture testing with 4-chloro-3-ethylphenol in malignant hyperthermia positive and negative human skeletal muscles［J］. Anesth Analg, 2005, 101(3): 710-714. ［8］Johi RR, Mills R, Halsall PJ, Hopkins PM. Anaesthetic management of coronary artery bypass grafting in a patient with central core disease and susceptibility to malignant hyperthermia on statin therapy［J］. Br J Anaesth, 2003, 91(5): 744-747. ［9］王颖林,郭向阳,罗艾伦.我国大陆恶性高热病例的分析［J］.中华麻醉学杂志,2006,26(2):107-109.